October 4th 2024
Increases in CRC screening were higher in high socioeconomic status and metropolitan areas, according to a new large cohort study.
September 17th 2024
Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.
T1D Antibody Screening: Identifying High-Risk Populations
Following audience polls, the panelists provide clinical insights into their screening practices for patients with type 1 diabetes, highlighting key antibodies they screen for.
T1D Staging: The Clinical Importance of Early Recognition
The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.
The Crucial Impact of Early Intervention in Preventing T1D Stage Progression
Addressing the significance of acting early in T1D care, a group of diabetes experts delve into the impact of delaying intervention during stage 2 of the condition.
Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?
May 3rd 2024New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.